Cardiology
Endocrinology
Dermatology
Gastroenterology
Geriatrics
Psychiatry
Pulmonology
Rheumatology
Dermatology
Abrocitinib Adds Second Positive Phase 3 Findings to Atopic Dermatitis
October 14, 2019
Tildrakizumab Sustains Four-Year Benefits in Plaque Psoriasis
October 11, 2019
Ixekizumab Shows Skin Clearance Superiority Over Guselkumab
October 08, 2019
Brad Glick, DO: New Agents in Psoriasis
October 06, 2019
FDA Approves New Topical Cream to Treat Acne
October 04, 2019
Abrocitinib Provides Skin Clearance, Itch Relief in 12-Week Trial
October 03, 2019
Brad Glick, DO: Improving Atopic Dermatitis Outcomes
October 02, 2019
Margaret Bobonich, DNP, DCNP: Using Biologic Therapies for Psoriasis, Atopic Dermatitis
September 24, 2019
FDA Approves Ixekizumab to Treat Active Ankylosing Spondylitis
August 26, 2019
Baricitinib Hits 16-Week Marks for Atopic Dermatitis
August 24, 2019
+ Load More
Copyright® ConsultantLive 2019 Intellisphere, LLC. All Rights Reserved.
